Extract
Phase Forward CEO Bob Weiler Named to PharmaVOICE 100 List and as a Finalist for the 2006 Mass Technology Leadership Awards, Recognized for Leadership and Outstanding Achievements.
WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that President and Chief Executive Officer Bob Weiler has been named to the prestigious PharmaVOICE 100 list. In addition, Weiler was named as a finalist for the Mass Technology Leadership Council's 2006 CEO of the Year awa...
See the full content of this document
Sponsored links
